Literature DB >> 28509071

Fever associated with severe dialysis-related amyloidosis.

Toshiaki Nakano1, Hiroshi Nagae2, Noboru Murakami2, Masatomo Taniguchi2, Hirofumi Ikeda2, Dai Matsuo2, Kazuhiko Tsuruya2, Takanari Kitazono2.   

Abstract

Dialysis-related amyloidosis (DRA) is one of the most important complications in patients on long-term hemodialysis (HD). DRA often affects the osteoarticular system; however, little is known about the role of β2-microglobulin in the induction of fever in HD patients. We report a 64-year-old woman on long-term (24 years) HD who developed polyarthralgia and intermittent fever. Infectious diseases, connective tissue diseases, and malignant neoplasm were ruled out. Computed tomography and magnetic resonance imaging showed swelling of the soft tissues around bilateral shoulder and hip joints, suggestive of amyloid deposits. Gallium scintigraphy showed abnormal uptake in the vicinity of several large joints. It was presumed that the fever was related to the amyloid joint deposits, and the patient was treated with prednisolone and β2-microglobulin adsorption therapy. The treatment resulted in the resolution of fever, relief of arthralgia, and normalization of several inflammatory cytokines and C-reactive protein. The findings suggest that massive DRA could cause systemic inflammatory response in patients on long-term HD.

Entities:  

Keywords:  Dialysis-related amyloidosis; Long-term hemodialysis; Systemic inflammatory response; β2-Microglobulin

Year:  2012        PMID: 28509071      PMCID: PMC5413646          DOI: 10.1007/s13730-012-0024-3

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  16 in total

1.  Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.

Authors:  C Garbar; M Jadoul; H Noël; C van Ypersele de Strihou
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

2.  beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis.

Authors:  F F Hou; T Miyata; J Boyce; Q Yuan; G M Chertow; J Kay; A M Schmidt; W F Owen
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

3.  Cells surrounding haemodialysis-associated amyloid deposits are mainly macrophages.

Authors:  A Argilés; G Mourad; P G Kerr; M García; B Collins; J G Demaille
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

4.  Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study.

Authors:  Shigeto Oda; Hiroyuki Hirasawa; Hidetoshi Shiga; Kazuya Nakanishi; Ken-Ichi Matsuda; Masataka Nakamura; Hiroyuki Ikeda; Masamune Sakai
Journal:  Blood Purif       Date:  2004-12-03       Impact factor: 2.614

5.  Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis.

Authors:  Fan Fan Hou; Jian Ping Jiang; Jun Qi Guo; Guo Bao Wang; Xun Zhang; David M Stern; Ann Marie Schmidt; William F Owen
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

6.  Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column.

Authors:  Fumitake Gejyo; Yoshindo Kawaguchi; Shigeko Hara; Ryoichi Nakazawa; Nakanobu Azuma; Hiroshi Ogawa; Yutaka Koda; Masashi Suzuki; Hiroshi Kaneda; Hidefumi Kishimoto; Mizue Oda; Kyoko Ei; Ryoichi Miyazaki; Hiroki Maruyama; Masaaki Arakawa; Mitsuru Hara
Journal:  Artif Organs       Date:  2004-04       Impact factor: 3.094

7.  Lixelle adsorbent to remove inflammatory cytokines.

Authors:  K Tsuchida; Y Takemoto; T Nakamura; O Fu; C Okada; S Yamagami; T Kishimoto
Journal:  Artif Organs       Date:  1998-12       Impact factor: 3.094

8.  Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.

Authors:  G Ehlerding; J Schaeffer; W Drommer; T Miyata; K M Koch; J Floege
Journal:  Nephrol Dial Transplant       Date:  1998-06       Impact factor: 5.992

9.  beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.

Authors:  T Miyata; O Oda; R Inagi; Y Iida; N Araki; N Yamada; S Horiuchi; N Taniguchi; K Maeda; T Kinoshita
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.

Authors:  T Miyata; R Inagi; Y Iida; M Sato; N Yamada; O Oda; K Maeda; H Seo
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more
  1 in total

1.  Persistent fever and destructive arthritis caused by dialysis-related amyloidosis: A case report.

Authors:  Kotaro Matsumoto; Jun Kikuchi; Yuko Kaneko; Hidekata Yasuoka; Kazuko Suzuki; Hirobumi Tokuyama; Kaori Kameyama; Kunihiro Yamaoka; Tsutomu Takeuchi
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.